Comparative Efficacy and Safety of Irreversible (Rasagiline) and Reversible (Safinamide) Monoamine Oxidase Inhibitors as Add-on Therapy for Parkinson’s Disease (P11-5.016)
This network meta-analysis aimed to examine the efficacy and safety of Safinamide and Rasagiline as add-on therapy in patients with Parkinson’s disease.
Authors
- Besher Shami (ORCID: https://orcid.org/0009-0002-0685-8991)
- Syed Ijlal Ahmed (ORCID: https://orcid.org/0000-0003-3896-6380)
- Faizan Shahzad (ORCID: https://orcid.org/0000-0002-8618-1521)
- Saad Hulou
- Maimoona Siddiqui
- M. N. Abedin
- Marwah Bintay Khalid
Institutions
- University of Aleppo (SY)
- University of Kentucky (US)
- Rawalpindi Medical University (PK)
- UCLouvain Saint-Louis Brussels (BE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211152
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00